Fundz

PreciseDx raised $20.7M in a Series B funding led by Eventide Asset Management to advance its AI-based breast cancer risk assessment.

PRIVATEAug 21, 2024

Amount Raised

$20.7 Million

Round Type

Series B

New YorkData And AnalyticsHealth CareScience And Engineering

Investors

Gen Henn Capital VentureQuest DiagnosticsLabcorpEventide Asset Management

Description

Cancer diagnostics startup PreciseDx secured $20.7 million in Series B funding to boost its commercialization efforts for an AI-driven breast cancer risk assessment. The round was supported by notable investors including Labcorp, Quest Diagnostics, and GenHenn Capital Venture.

Quick answer

PreciseDx raised $20.7 Million in a Series B round, dated August 21, 2024. Investors: Gen Henn Capital Venture, Quest Diagnostics, Labcorp and Eventide Asset Management. PreciseDx is based in New York, New York, United States.

How much did PreciseDx raise?
PreciseDx raised $20.7 Million in a Series B round on August 21, 2024.
Who invested in PreciseDx?
Gen Henn Capital Venture, Quest Diagnostics, Labcorp and Eventide Asset Management are named as investors in this round.
What does PreciseDx do?
PreciseDx is a leading innovator in AI-powered, patient-specific disease analysis.
Where is PreciseDx based and how big is it?
PreciseDx is based in New York, New York, United States.
Who are the decision-makers at PreciseDx?
Fundz holds 1 contact at PreciseDx. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Data And Analytics and Science And Engineering around the same time

Companies in the same sectors as PreciseDx that raised within 45 days of this round, from Fundz verified event records.

  • Cardurion Pharmaceuticals raised $260M (Series B) on July 16, 2024.
  • Cardurion Pharmaceuticals raised $260M (Series B) on July 16, 2024.
  • Cardurion Pharmaceuticals raised $260M on July 10, 2024.
  • Neuron7.ai raised $45M on September 27, 2024.
  • 22nd Century raised $1.2M (Seed) on September 27, 2024.
  • PBS Biotech raised $8.5M on September 11, 2024.

Who to call at PreciseDx, and when

A new round usually means PreciseDx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PreciseDx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PreciseDx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PreciseDx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PreciseDx

Location

New York, New York, United States

About

PreciseDx is a leading innovator in AI-powered, patient-specific disease analysis. PreciseDx’s Morphology Feature Array™ provides clinical teams with unmatched information and accurate, actionable intelligence for disease state characterization, supporting personalized patient management.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PreciseDx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for PreciseDx's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

PreciseDx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.